| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161645 Thiazole inhibitors targeting resistant kinase mutations |
| 07/12/2007 | US20070161644 Erastin analogs and uses thereof |
| 07/12/2007 | US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin |
| 07/12/2007 | US20070161642 Drug for inhibiting vascular intimal hyperplasia |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161639 Hiv integrase inhibitors |
| 07/12/2007 | US20070161638 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide |
| 07/12/2007 | US20070161637 Substituted pyridin-2-ylamine analogues |
| 07/12/2007 | US20070161636 Binding target to photoactive compound then irradiating with xenon arc lamp |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161632 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
| 07/12/2007 | US20070161631 Substituted Phenoxyacetic Acids |
| 07/12/2007 | US20070161630 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/12/2007 | US20070161629 A1 Adenosine Receptor Antagonists |
| 07/12/2007 | US20070161628 Phosphodiesterase inhibitors |
| 07/12/2007 | US20070161627 Antibacterial agents |
| 07/12/2007 | US20070161626 Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof |
| 07/12/2007 | US20070161625 phenothiazinium compounds; for healing process and cosmetic uses; for problems associated with vascular disease, malnutrition, stress, cancer radio- or chemotherapy, compromise of immune system or due to normal aging process; as a cream, suspension, emulsion, gel, ointment, salve, stick, soap, paste |
| 07/12/2007 | US20070161624 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 07/12/2007 | US20070161623 Urea derivatives |
| 07/12/2007 | US20070161622 Diamino alcohols and their use as renin inhibitor |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |
| 07/12/2007 | US20070161619 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof |
| 07/12/2007 | US20070161618 Isothiourea derivatives |
| 07/12/2007 | US20070161617 Certain chemical entities, compositions and methods |
| 07/12/2007 | US20070161616 Method for treating glaucoma IIB |
| 07/12/2007 | US20070161615 Chemical compounds |
| 07/12/2007 | US20070161614 Pyridylether derivatives, their preparation and use |
| 07/12/2007 | US20070161613 Platinum complexes and methods for inhibiting tumor cell proliferation |
| 07/12/2007 | US20070161612 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound |
| 07/12/2007 | US20070161611 Polycyclic phenolic compounds and use in treating viral infections |
| 07/12/2007 | US20070161610 Bipolar trans carotenoid salts and their uses |
| 07/12/2007 | US20070161609 Use of mitochondrially targeted antioxidant in treatment and prevention of drug-induced liver disease |
| 07/12/2007 | US20070161608 Cachexia, bone disorders |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161606 Solid and crystalline ibandronic acid |
| 07/12/2007 | US20070161605 Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring |
| 07/12/2007 | US20070161604 urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases |
| 07/12/2007 | US20070161603 Method of administering bisphosphonates |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161601 Propofol formulation containing reduced oil and surfactants |
| 07/12/2007 | US20070161600 Methods and compositions for administration of iron |
| 07/12/2007 | US20070161599 Composition for blocking hiv binding to dendritic cells and methods of use thereof |
| 07/12/2007 | US20070161598 Compositions and methods for treatment of disease with acetylated disaccharides |
| 07/12/2007 | US20070161597 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 07/12/2007 | US20070161587 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
| 07/12/2007 | US20070161586 Drug for preventing and treating atherosclerosis |
| 07/12/2007 | US20070161585 Immunopotentiator and method for enhancing immunoactivity using the same |
| 07/12/2007 | US20070161583 increasing patient compliance in treatment of hepatitis-C virus infection; tablets; blister packs |
| 07/12/2007 | US20070161582 Pharmaceutical compositions and methods for metabolic modulation |
| 07/12/2007 | US20070161581 Novel aminoglycoside antibiotics effective against methicillin resistant staphylococcus auerus (mrsas) |
| 07/12/2007 | US20070161580 Anti-Tumor Compounds With Angeloyl Groups |
| 07/12/2007 | US20070161579 Nymphaeol-A, nymphaeol-B and nymphaeol-C; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement |
| 07/12/2007 | US20070161578 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist |
| 07/12/2007 | US20070161577 Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones |
| 07/12/2007 | US20070161576 Drugs for chronic pains |
| 07/12/2007 | US20070161573 Selective targeting agents for mitochondria |
| 07/12/2007 | US20070161571 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 07/12/2007 | US20070161563 A device for enhanced epithelial permeation of y2 receptor-binding peptides |
| 07/12/2007 | US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/12/2007 | US20070161559 Method for the treatment of gout or pseudogout |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161551 Methods and compositions for the treatment of lipodystrophy |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161544 Selective targeting agents for mitcochondria |
| 07/12/2007 | US20070161543 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 07/12/2007 | US20070161540 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 07/12/2007 | US20070161073 Methods and products related to evaluating the quality of a polysaccharide |
| 07/12/2007 | US20070161072 Neuroprotection by inhibition of diacyglycerol kinase epsilon activity |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070160981 Viral protease |
| 07/12/2007 | US20070160698 Muscular strength enhancing agent |
| 07/12/2007 | US20070160694 Preventives or remedies for tumor or human papillomaviral disease |
| 07/12/2007 | US20070160692 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 07/12/2007 | US20070160691 Pharmaceutical composition for treating and preventing cancer comprising cinnamoni cortex extract and zizyphi fructus extract |
| 07/12/2007 | US20070160690 Composition and method to augment and sustain neurotransmitter production |
| 07/12/2007 | US20070160689 Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 07/12/2007 | US20070160688 Use of flavonoids to increase blood serum levels of dehydroepiandrosterone |
| 07/12/2007 | US20070160684 Methods for increasing cancer cell chemosensitivity |
| 07/12/2007 | US20070160683 Electrolyte supplement and method of use |
| 07/12/2007 | US20070160680 Fluid composition used to stimulate human synovial fluid |
| 07/12/2007 | US20070160678 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 07/12/2007 | US20070160676 Stable dispersion of DBNPA in viscosified brine |
| 07/12/2007 | US20070160675 Preferably cefdinir, in rapid dissolving tablets that release the drug a bimodal, multimodal or continuous manner |
| 07/12/2007 | US20070160673 Amoxicilline instant granulate |
| 07/12/2007 | US20070160671 Biguanide formulations |
| 07/12/2007 | US20070160670 Compression-coated tablets and manufacture thereof |
| 07/12/2007 | US20070160669 Delayed release carnitine |
| 07/12/2007 | US20070160668 Prolonged release bioadhesive therapeutic systems |
| 07/12/2007 | US20070160666 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; free of ascorbic acid and pregelatinized starch; for treatment of atheroslerosis; stability |
| 07/12/2007 | US20070160665 Chlorthalidone combinations |
| 07/12/2007 | US20070160664 Pharmaceutical compositions comprising of proton pump inhibitor and prokinetic agent |
| 07/12/2007 | US20070160663 Single unit pharmaceutical composition comprising a mixture of fenofibrate and a modified release form of a homocysteine reducing agent |
| 07/12/2007 | US20070160661 Aspirin formulation for cardiovascular health |